Clinical Trials Logo

Clinical Trial Summary

Alexithymia is often found in patients suffering from anorexia nervosa or from bulimia. Art-therapy is widely used in this indication without there is a study in the literature assessing it. ALEXART is an observational prospective multicenter cohort pilot study, assessing the effect at 3 months of art therapy on alexithymia, in patients presenting anorexia nervosa or bulimia.


Clinical Trial Description

Alexithymia, defined by difficulties to identify and describe feelings as well as a poverty of imaginary life, is found in patients with anorexia nervosa (AN) or bulimia (BN) in numerous studies. Some publications show that it is a factor of resistance in several forms of psychotherapies and of poor prognosis for these patients who already present a high rate of chronification and mortality because of the complications of the undernutrition and the suicide risk. Art therapy is very wide-spread in the care of AN and of BN, but little studied. About alexithymia, if there is no psychotherapy having made the proof of its efficiency currently, some studies suggest the interest of art-therapy on alexithymic features, but none, to our knowledge, estimated the effect.

The investigator suggest to describe the evolution at 3 months of art therapy on alexithymia, using the Toronto Alexithymia Scale in 20 items (TAS-20), in patients with AN or BN. The investigators shall also describe the evolution at 3 months with the TAS-20 as well as the relationship between variations of alexithymia and BMI in patients presenting AN at 1 and 3 months globally and in each of the centers. The investigators will also evaluate the effect of depression and anxiety at 1 and 3 months of art therapy on alexithymia.The investigators shall realize an observational prospective multicenter cohort study design. Each patient will receive standard care: multidisciplinary and corresponding to the HAS recommendations and semimonthly or weeklies sessions of art therapy, using all types of art. Thus, each patient will be her own control before art therapy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03524443
Study type Observational
Source University Hospital, Toulouse
Contact Clara LETAMENDIA, MD
Phone 05 34 55 75 25
Email letamendia.c@chu-toulouse.fr
Status Not yet recruiting
Phase
Start date October 2018
Completion date June 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05575960 - Interpersonal Psychotherapy for Adolescents and Young Adults N/A
Recruiting NCT03855553 - Project CORE: Disseminating Eating Disorders Treatment Phase 1
Enrolling by invitation NCT04869423 - Animal-Assisted Therapy in Adolescents With Eating Disorders N/A
Enrolling by invitation NCT05073679 - Oral Naltrexone In Pediatric Eating Disorders Phase 2/Phase 3